Niagen Bioscience, Inc. (NAGE) — Cash Flow Quality Index
Niagen Bioscience, Inc. (NAGE) has a Cash Flow Quality Index of 0.81x as of September 2025. Operating cash flow of $3.69 Million is below net income of $4.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Niagen Bioscience, Inc. to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Niagen Bioscience, Inc. Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Niagen Bioscience, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Niagen Bioscience, Inc. (NAGE) cash flow conversion.
Annual Cash Flow Quality Index for Niagen Bioscience, Inc. (2024–2024)
Year-by-year earnings quality comparison for Niagen Bioscience, Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.42x | $12.11 Million | $8.55 Million | — |